Dow Up 0.08% Nasdaq Down 0.30%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
5.28 Down 0.29(5.21%) Sep 19, 4:00PM EDT
Prev Close:5.57
Open:5.50
Bid:5.12 x 500
Ask:6.72 x 100
1y Target Est:24.00
Beta:1.04
Next Earnings Date:N/A
Day's Range:5.26 - 5.75
52wk Range:4.28 - 19.11
Volume:323,864
Avg Vol (3m):760,291
Market Cap:116.39M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTDown 5.21%116.39M
MNTADown 0.69%593.10M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.03
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback